Literature DB >> 3799155

Maximal response to oxytocin of the isolated myometrium from pregnant patients with intrahepatic cholestasis.

E J Israel, M L Guzman, G A Campos.   

Abstract

Prematurity and fetal death are common complications in patients with cholestasis of pregnancy. Both conditions appear to be associated with abnormal patterns of uterine activity. We studied the oxytocin-induced contractile activity in uterine strips taken from patients with cholestasis of pregnancy (n = 6) and from women with normal pregnancy (n = 6). Contractile activity of the myometrium in response to oxytocin was significantly higher in patients with cholestasis of pregnancy than in normally pregnant patients, at doses of 10(-6), 10(-4), and 10(-2) M. We found that there is a greater maximal response to oxytocin in strips of myometrium from patients with cholestasis of pregnancy than from normally pregnant patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799155     DOI: 10.3109/00016348609158391

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

Review 1.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

2.  Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study.

Authors:  Victoria Geenes; Lucy C Chappell; Paul T Seed; Philip J Steer; Marian Knight; Catherine Williamson
Journal:  Hepatology       Date:  2014-02-26       Impact factor: 17.425

3.  Intrahepatic cholestasis of pregnancy: Relationship between bile acid levels and maternal and fetal complications.

Authors:  Bilge Çetinkaya Demir; Esra Şahin Güneş; Mehmet Aral Atalay
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

4.  Dysregulation of bile acids increases the risk for preterm birth in pregnant women.

Authors:  Sangmin You; Ai-Min Cui; Syed F Hashmi; Xinmu Zhang; Christina Nadolny; Yuan Chen; Qiwen Chen; Xin Bush; Zachary Hurd; Winifer Ali; Gang Qin; Ruitang Deng
Journal:  Nat Commun       Date:  2020-04-30       Impact factor: 14.919

5.  Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.

Authors:  Caroline Ovadia; Jenna Sajous; Paul T Seed; Kajol Patel; Nicholas J Williamson; George Attilakos; Francesco Azzaroli; Yannick Bacq; Linoy Batsry; Kelsey Broom; Romana Brun-Furrer; Laura Bull; Jenny Chambers; Yue Cui; Min Ding; Peter H Dixon; Maria C Estiú; Fergus W Gardiner; Victoria Geenes; Monika Grymowicz; Berrin Günaydin; William M Hague; Christian Haslinger; Yayi Hu; Ugo Indraccolo; Alexander Juusela; Stefan C Kane; Ayse Kebapcilar; Levent Kebapcilar; Katherine Kohari; Jūratė Kondrackienė; Maria P H Koster; Richard H Lee; Xiaohua Liu; Anna Locatelli; Rocio I R Macias; Riza Madazli; Agata Majewska; Kasia Maksym; Jessica A Marathe; Adam Morton; Martijn A Oudijk; Deniz Öztekin; Michael J Peek; Andrew H Shennan; Rachel M Tribe; Valeria Tripodi; Naciye Türk Özterlemez; Tharni Vasavan; L F Audris Wong; Yoav Yinon; Qianwen Zhang; Keren Zloto; Hanns-Ulrich Marschall; Jim Thornton; Lucy C Chappell; Catherine Williamson
Journal:  Lancet Gastroenterol Hepatol       Date:  2021-04-27

6.  Development of an adverse outcome pathway for intrahepatic cholestasis of pregnancy.

Authors:  Jennifer Waspe; Anna Beronius
Journal:  Curr Res Toxicol       Date:  2022-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.